Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavia Longo

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Tumori|December 31, 2008
[ASCO 2008. Bevacizumab in advanced renal carcinoma]Giovanni Mansueto, Flavia Longo
Tumori|May 13, 2008
[Biopharmaceuticals and biosimilars in oncology: where are we?]Flavia Longo, Alessandro Maturo
Tumori|May 11, 2006
[ECCO 2005. Advances in the prevention of chemotherapy-induced nausea and vomiting]Flavia Longo, Giovanni Mansueto, Emanuela Magnolfi
Tumori|November 11, 2003
[ASCO 2003--What is changing in the treatment of colorectal cancer]Flavia Longo, Giovanni Mansueto, Giuseppe Colucci
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 25, 2012
Role of HE4, CA72.4, and CA125 in monitoring ovarian cancerTeresa Granato, Cecilia Midulla, Flavia Longo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 21, 2015
HE4 in the differential diagnosis of ovarian massesTeresa Granato, Maria Grazia Porpora, Flavia Longo, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 21, 2012
HE4 combined with MDCT imaging is a good marker in the evaluation of disease extension in advanced epithelial ovarian carcinomaCecilia Midulla, Lucia Manganaro, Flavia Longo, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 19, 2013
Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markersRenato Falzarano, Valentina Viggiani, Simona Michienzi, et al.
Case Reports in Oncological Medicine|September 28, 2013
Merkel cell carcinoma of the retroperitoneum with no identifiable primary siteDaniele Rossini, Salvatore Caponnetto, Vittoria Lapadula, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 30, 2013
Circulating tumor cells in high-risk nonmetastatic colorectal cancerPaola Gazzaniga, Walter Gianni, Cristina Raimondi, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Tumori|December 31, 2008
[ASCO 2008. Bevacizumab in advanced renal carcinoma]Giovanni Mansueto, Flavia Longo
Tumori|May 13, 2008
[Biopharmaceuticals and biosimilars in oncology: where are we?]Flavia Longo, Alessandro Maturo
Tumori|May 11, 2006
[ECCO 2005. Advances in the prevention of chemotherapy-induced nausea and vomiting]Flavia Longo, Giovanni Mansueto, Emanuela Magnolfi
Tumori|November 11, 2003
[ASCO 2003--What is changing in the treatment of colorectal cancer]Flavia Longo, Giovanni Mansueto, Giuseppe Colucci
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 25, 2012
Role of HE4, CA72.4, and CA125 in monitoring ovarian cancerTeresa Granato, Cecilia Midulla, Flavia Longo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 21, 2015
HE4 in the differential diagnosis of ovarian massesTeresa Granato, Maria Grazia Porpora, Flavia Longo, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 21, 2012
HE4 combined with MDCT imaging is a good marker in the evaluation of disease extension in advanced epithelial ovarian carcinomaCecilia Midulla, Lucia Manganaro, Flavia Longo, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 19, 2013
Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markersRenato Falzarano, Valentina Viggiani, Simona Michienzi, et al.
Case Reports in Oncological Medicine|September 28, 2013
Merkel cell carcinoma of the retroperitoneum with no identifiable primary siteDaniele Rossini, Salvatore Caponnetto, Vittoria Lapadula, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 30, 2013
Circulating tumor cells in high-risk nonmetastatic colorectal cancerPaola Gazzaniga, Walter Gianni, Cristina Raimondi, et al.
Pageof 8